EA001915B1
(ru)
|
1996-10-18 |
2001-10-22 |
Вертекс Фармасьютикалз Инкорпорейтед |
Ингибиторы серин-протеаз, в частности ns3 протеазы вируса гепатита c (hvc)
|
KR20100003313A
(ko)
*
|
2000-04-13 |
2010-01-07 |
파마셋 인코포레이티드 |
간염 바이러스 감염 치료를 위한 3'- 또는 2'-하이드록시메틸 치환된 뉴클레오시드 유도체
|
MY164523A
(en)
*
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
CN1315862C
(zh)
*
|
2000-05-26 |
2007-05-16 |
艾登尼科斯(开曼)有限公司 |
处理黄病毒和瘟病毒的方法和组合物
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
SK286630B6
(sk)
*
|
2001-01-22 |
2009-02-05 |
Merck & Co., Inc. |
Nukleozidové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
|
US8481712B2
(en)
*
|
2001-01-22 |
2013-07-09 |
Merck Sharp & Dohme Corp. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
CA2434845C
(en)
|
2001-01-23 |
2013-11-19 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Hepatitis c virus replicons and replicon enhanced cells
|
US6905669B2
(en)
|
2001-04-24 |
2005-06-14 |
Supergen, Inc. |
Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
JP2005504087A
(ja)
*
|
2001-09-28 |
2005-02-10 |
イデニクス(ケイマン)リミテツド |
4’が修飾されたヌクレオシドを使用するc型肝炎ウイルス治療のための方法および組成物
|
AU2002353164A1
(en)
*
|
2001-12-17 |
2003-06-30 |
Ribapharm Inc. |
Unusual nucleoside libraries, compounds, and preferred uses as antiviral and anticancer agents
|
WO2003062256A1
(en)
*
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
WO2003062255A2
(en)
*
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
Sugar modified nucleosides as viral replication inhibitors
|
CA2474563C
(en)
|
2002-02-13 |
2010-11-09 |
Merck & Co., Inc. |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
|
AU2003260578A1
(en)
*
|
2002-04-04 |
2003-10-20 |
Achillion Pharmaceuticals, Inc. |
Hcv antiviral and cytotoxicity drug screening assay
|
EP1495040A4
(en)
*
|
2002-04-12 |
2006-01-25 |
Achillion Pharmaceuticals Inc |
PROCESS FOR THE SYNTHESIS OF BETA-L-FLUORO-2 ', 3'-DIDEOXY-DIDEHYDROCYTIDINE (BETA-L-FD4C)
|
US20060128692A1
(en)
|
2002-04-26 |
2006-06-15 |
Gilead Sciences, Inc |
Non nucleoside reverse transcriptase inhibitors
|
US7247621B2
(en)
|
2002-04-30 |
2007-07-24 |
Valeant Research & Development |
Antiviral phosphonate compounds and methods therefor
|
RU2004135392A
(ru)
*
|
2002-05-06 |
2005-06-27 |
Дженелэбс Текнолоджиз, Инк. (Us) |
Производные нуклеозидов для лечения инфекции, вызываемой вирусом гепатита с
|
US6982253B2
(en)
|
2002-06-05 |
2006-01-03 |
Supergen, Inc. |
Liquid formulation of decitabine and use of the same
|
AU2003269890A1
(en)
*
|
2002-06-21 |
2004-01-06 |
Isis Pharmaceuticals, Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
EP1572945A2
(en)
*
|
2002-06-27 |
2005-09-14 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
NZ537662A
(en)
|
2002-06-28 |
2007-10-26 |
Idenix Cayman Ltd |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
CN1678326A
(zh)
|
2002-06-28 |
2005-10-05 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2'-c-甲基-3'-o-l-缬氨酸酯核糖呋喃基胞苷
|
TW200500374A
(en)
*
|
2002-06-28 |
2005-01-01 |
Idenlx Cayman Ltd |
2' and 3' -nucleoside produrgs for treating flavivridae infections
|
GB0215293D0
(en)
|
2002-07-03 |
2002-08-14 |
Rega Foundation |
Viral inhibitors
|
CA2490666A1
(en)
*
|
2002-07-16 |
2004-01-22 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
AU2003256619A1
(en)
|
2002-07-24 |
2004-02-09 |
Isis Pharmaceuticals, Inc. |
Pyrrolopyrimidine thionucleoside analogs as antivirals
|
WO2004011478A2
(en)
*
|
2002-07-25 |
2004-02-05 |
Micrologix Biotech Inc. |
Anti-viral 7-deaza d-nucleosides and uses thereof
|
CA2493949C
(en)
|
2002-07-26 |
2015-06-02 |
Chiron Corporation |
Modified small interfering rna molecules and methods of use
|
MXPA05001298A
(es)
*
|
2002-08-01 |
2005-11-04 |
Pharmasset Inc |
Compuestos con el sistema biciclo[4.2.1] nonano para el tratamiento de infecciones por flaviviridae.
|
US20040067877A1
(en)
|
2002-08-01 |
2004-04-08 |
Schinazi Raymond F. |
2', 3'-Dideoxynucleoside analogues for the treatment or prevention of Flaviviridae infections
|
DE10238722A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
|
US7094768B2
(en)
*
|
2002-09-30 |
2006-08-22 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis C virus infection
|
US7425547B2
(en)
|
2002-09-30 |
2008-09-16 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis C virus infection
|
US20050075279A1
(en)
|
2002-10-25 |
2005-04-07 |
Boehringer Ingelheim International Gmbh |
Macrocyclic peptides active against the hepatitis C virus
|
BR0315806A
(pt)
*
|
2002-10-31 |
2005-09-13 |
Metabasis Therapeutics Inc |
Fosfato diésteres cìclicos de 1,3-propano-1-aril diós e seu uso na preparação de pró-drogas
|
CA2506129C
(en)
|
2002-11-15 |
2015-02-17 |
Idenix (Cayman) Limited |
2'-branched nucleosides and flaviviridae mutation
|
US7034167B2
(en)
|
2002-12-06 |
2006-04-25 |
Merck & Co., Inc. |
Process to ribofuranose sugar derivatives as intermediates to branched-chain nucleosides
|
EP2319853B1
(en)
|
2002-12-12 |
2014-03-12 |
IDENIX Pharmaceuticals, Inc. |
Process for the production of 2'-branched nucleosides
|
KR20050110611A
(ko)
*
|
2002-12-23 |
2005-11-23 |
이데닉스 (케이만) 리미티드 |
3'-뉴클레오사이드 프로드럭의 생산 방법
|
DE60331367D1
(de)
|
2002-12-30 |
2010-04-01 |
Angiotech Int Ag |
Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
AR043006A1
(es)
*
|
2003-02-12 |
2005-07-13 |
Merck & Co Inc |
Proceso para preparar ribonucleosidos ramificados
|
MXPA05010419A
(es)
*
|
2003-03-28 |
2006-05-31 |
Pharmasset Inc |
Compuestos para el tratamiento de infecciones por flaviviridae.
|
GB0307891D0
(en)
*
|
2003-04-04 |
2003-05-14 |
Angeletti P Ist Richerche Bio |
Chemical compounds,compositions and uses
|
US7417055B2
(en)
|
2003-04-25 |
2008-08-26 |
Gilead Sciences, Inc. |
Kinase inhibitory phosphonate analogs
|
WO2004096287A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
US7429565B2
(en)
|
2003-04-25 |
2008-09-30 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
WO2004096285A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Anti-infective phosphonate conjugates
|
WO2005002626A2
(en)
*
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
US20040259934A1
(en)
*
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
SI2604620T1
(sl)
|
2003-05-30 |
2016-10-28 |
Gilead Pharmasset LLC c/o Gilead Sciences, Inc. |
Modificirani fluorirani nukleozidni analogi
|
WO2004108687A2
(en)
|
2003-06-04 |
2004-12-16 |
Genelabs Technologies, Inc. |
Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection
|
US7429596B2
(en)
*
|
2003-06-20 |
2008-09-30 |
The Regents Of The University Of California |
1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
|
US7572581B2
(en)
|
2003-06-30 |
2009-08-11 |
Roche Molecular Systems, Inc. |
2′-terminator nucleotide-related methods and systems
|
RU2361875C2
(ru)
*
|
2003-06-30 |
2009-07-20 |
Айденикс (Кайман) Лимитед |
СИНТЕЗ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ
|
US7947817B2
(en)
|
2003-06-30 |
2011-05-24 |
Roche Molecular Systems, Inc. |
Synthesis and compositions of 2'-terminator nucleotides
|
ES2351603T3
(es)
*
|
2003-07-25 |
2011-02-08 |
Idenix Pharmaceuticals, Inc. |
Análogos de nucleósidos de purina para el tratamiento de enfermedades causadas por flaviridae incluyendo hepatitis c.
|
CA2534649A1
(en)
|
2003-08-01 |
2005-02-10 |
Genelabs Technologies, Inc. |
Bicyclic imidazol derivatives against flaviviridae
|
WO2005018330A1
(en)
*
|
2003-08-18 |
2005-03-03 |
Pharmasset, Inc. |
Dosing regimen for flaviviridae therapy
|
CN1863813B
(zh)
|
2003-08-27 |
2011-03-30 |
生物区科学管理控股有限公司 |
作为治疗剂的三环核苷或核苷酸
|
TW201127828A
(en)
|
2003-09-05 |
2011-08-16 |
Vertex Pharma |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
MXPA06003963A
(es)
|
2003-10-14 |
2006-08-25 |
Intermune Inc |
Acidos carboxilicos macrociclicos y acilsulfonamidas como inhibidores de replicacion del hcv.
|
US7144868B2
(en)
*
|
2003-10-27 |
2006-12-05 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
US7432273B2
(en)
|
2003-10-24 |
2008-10-07 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
JP2007508843A
(ja)
|
2003-10-24 |
2007-04-12 |
ギリアード サイエンシーズ, インコーポレイテッド |
治療用化合物の同定のための方法および組成物
|
WO2005044279A1
(en)
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Purine nucleoside phosphonate conjugates
|
AU2004295291A1
(en)
*
|
2003-10-27 |
2005-06-16 |
Smithkline Beecham Corporation |
Nucleoside compounds for treating viral infections
|
US7202223B2
(en)
|
2003-10-27 |
2007-04-10 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
US7169918B2
(en)
|
2003-10-27 |
2007-01-30 |
Genelabs Technologies, Inc. |
Methods for preparing 7-(2′-substituted-β-D-ribofuranosyl)-4-(NR2R3)-5-(substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine derivatives
|
EP1680436A1
(en)
|
2003-10-27 |
2006-07-19 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
WO2005063751A1
(en)
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
4’-substituted carbovir-and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity
|
US20070258946A1
(en)
*
|
2003-12-23 |
2007-11-08 |
Blatt Lawrence M |
Combination Therapy for Treating Hepatitis C Virus Infection
|
WO2005062949A2
(en)
*
|
2003-12-23 |
2005-07-14 |
Intermune, Inc. |
Method for treating hepatitis virus infection
|
GB0500020D0
(en)
|
2005-01-04 |
2005-02-09 |
Novartis Ag |
Organic compounds
|
ES2358333T3
(es)
|
2004-01-21 |
2011-05-09 |
Boehringer Ingelheim International Gmbh |
Péptidos macrocíclicos con acción contra el virus de la hepatitis c.
|
US20050182252A1
(en)
*
|
2004-02-13 |
2005-08-18 |
Reddy K. R. |
Novel 2'-C-methyl nucleoside derivatives
|
UA86962C2
(en)
|
2004-02-20 |
2009-06-10 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Viral polymerase inhibitors
|
US7754718B2
(en)
|
2004-05-05 |
2010-07-13 |
Yale University |
Antiviral helioxanthin analogs
|
EP1758453B1
(en)
|
2004-06-15 |
2014-07-16 |
Merck Sharp & Dohme Corp. |
C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
|
CA2571675A1
(en)
*
|
2004-06-23 |
2006-01-05 |
Idenix (Cayman) Limited |
5-aza-7-deazapurine derivatives for treating infections with flaviviridae
|
US20070265222A1
(en)
*
|
2004-06-24 |
2007-11-15 |
Maccoss Malcolm |
Nucleoside Aryl Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
|
US7745125B2
(en)
|
2004-06-28 |
2010-06-29 |
Roche Molecular Systems, Inc. |
2′-terminator related pyrophosphorolysis activated polymerization
|
JP4283738B2
(ja)
*
|
2004-07-08 |
2009-06-24 |
浜松ホトニクス株式会社 |
半導体レーザ装置
|
NZ552927A
(en)
*
|
2004-07-21 |
2010-05-28 |
Pharmasset Inc |
Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
JP2008508291A
(ja)
|
2004-07-27 |
2008-03-21 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗hiv剤としてのヌクレオシドホスホネート結合体
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
JP2006077004A
(ja)
*
|
2004-08-11 |
2006-03-23 |
Chugai Pharmaceut Co Ltd |
抗hcv作用を有する化合物およびそれを含む医薬組成物
|
DE602005015466D1
(de)
*
|
2004-08-23 |
2009-08-27 |
Hoffmann La Roche |
Antivirale 4'-azidonucleoside
|
EP3109244B1
(en)
|
2004-09-14 |
2019-03-06 |
Gilead Pharmasset LLC |
Preparation of 2'fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
|
KR20070061570A
(ko)
*
|
2004-10-01 |
2007-06-13 |
버텍스 파마슈티칼스 인코포레이티드 |
Hcv ns3-ns4a 프로테아제 저해
|
WO2006065335A2
(en)
*
|
2004-10-21 |
2006-06-22 |
Merck & Co., Inc. |
Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of rna-dependent rna viral infection
|
US8133870B2
(en)
|
2004-10-29 |
2012-03-13 |
Biocryst Pharmaceuticals, Inc. |
Therapeutic furopyrimidines and thienopyrimidines
|
TW201424733A
(zh)
|
2004-10-29 |
2014-07-01 |
Vertex Pharma |
劑量型式
|
WO2006068760A2
(en)
|
2004-11-19 |
2006-06-29 |
The Regents Of The University Of California |
Anti-inflammatory pyrazolopyrimidines
|
WO2006121468A1
(en)
*
|
2004-11-22 |
2006-11-16 |
Genelabs Technologies, Inc. |
5-nitro-nucleoside compounds for treating viral infections
|
EA200701849A1
(ru)
|
2005-02-28 |
2008-02-28 |
Дженелабс Текнолоджис, Инк. |
Пролекарственные соединения трициклических нуклеозидов, фармацевтическая композиция на их основе и способ лечения и/или ингибирования вирусной инфекции у млекопитающего
|
US7524831B2
(en)
|
2005-03-02 |
2009-04-28 |
Schering Corporation |
Treatments for Flaviviridae virus infection
|
CA2600886A1
(en)
|
2005-03-08 |
2006-09-14 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
EP1898934A1
(en)
*
|
2005-03-09 |
2008-03-19 |
Idenix (Cayman) Limited |
Nucleosides with non-natural bases as anti-viral agents
|
US7250416B2
(en)
*
|
2005-03-11 |
2007-07-31 |
Supergen, Inc. |
Azacytosine analogs and derivatives
|
JP4516863B2
(ja)
*
|
2005-03-11 |
2010-08-04 |
株式会社ケンウッド |
音声合成装置、音声合成方法及びプログラム
|
WO2006101911A1
(en)
|
2005-03-16 |
2006-09-28 |
Case Western Reserve University |
Selective inhibitors of translesion dna replication
|
US9029345B2
(en)
*
|
2005-03-16 |
2015-05-12 |
Case Western Reserve University |
Selective inhibitors of translesion DNA replication
|
WO2006102594A1
(en)
*
|
2005-03-23 |
2006-09-28 |
Genelabs Technologies, Inc. |
Nucleoside prodrugs for treating viral infections
|
WO2007084157A2
(en)
*
|
2005-03-23 |
2007-07-26 |
Genelabs Technologies, Inc. |
Nucleoside prodrugs for treating viral infections
|
EP2537520A1
(en)
|
2005-03-29 |
2012-12-26 |
Biocryst Pharmaceuticals, Inc. |
Hepatics C therapies
|
US20090156545A1
(en)
*
|
2005-04-01 |
2009-06-18 |
Hostetler Karl Y |
Substituted Phosphate Esters of Nucleoside Phosphonates
|
TW200720285A
(en)
|
2005-04-25 |
2007-06-01 |
Genelabs Tech Inc |
Nucleoside compounds for treating viral infections
|
JP4705164B2
(ja)
|
2005-05-02 |
2011-06-22 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Hcvns3プロテアーゼ阻害剤
|
WO2006122207A1
(en)
*
|
2005-05-10 |
2006-11-16 |
Valeant Research & Development |
6-hydrazinopurine 2'-methyl ribonucleosides and nucleotides for treatment of hcv
|
KR20080016597A
(ko)
|
2005-05-13 |
2008-02-21 |
바이로켐 파마 인코포레이티드 |
플라비바이러스 감염의 예방 또는 치료용 화합물 및 그의예방 또는 치료 방법
|
CN100478349C
(zh)
*
|
2005-06-20 |
2009-04-15 |
河南省凯特化学实业总公司 |
氟化核苷类化合物、其制备方法及其应用
|
TWI387603B
(zh)
|
2005-07-20 |
2013-03-01 |
Merck Sharp & Dohme |
Hcv ns3蛋白酶抑制劑
|
EP1913016B1
(en)
|
2005-08-01 |
2013-01-16 |
Merck Sharp & Dohme Corp. |
Macrocyclic peptides as hcv ns3 protease inhibitors
|
EP2402331A1
(en)
*
|
2005-08-02 |
2012-01-04 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
US7700567B2
(en)
|
2005-09-29 |
2010-04-20 |
Supergen, Inc. |
Oligonucleotide analogues incorporating 5-aza-cytosine therein
|
EP1957510A1
(en)
|
2005-12-09 |
2008-08-20 |
F.Hoffmann-La Roche Ag |
Antiviral nucleosides
|
CA2634749C
(en)
|
2005-12-23 |
2014-08-19 |
Idenix Pharmaceuticals, Inc. |
Process for preparing a synthetic intermediate for preparation of branched nucleosides
|
JP2009526070A
(ja)
*
|
2006-02-09 |
2009-07-16 |
シェーリング コーポレイション |
Hcvプロテアーゼ阻害薬とhcvポリメラーゼ阻害薬との組み合わせ、ならびにそれらに関連する処置の方法
|
EP1991229A2
(en)
|
2006-02-27 |
2008-11-19 |
Vertex Pharmaceuticals Incorporated |
Co-crystals and pharmaceutical compositions comprising the same
|
NZ571280A
(en)
|
2006-03-16 |
2011-10-28 |
Vertex Pharma |
Deuterated hepatitis C protease inhibitors
|
EP2004634A1
(en)
|
2006-04-04 |
2008-12-24 |
F.Hoffmann-La Roche Ag |
3',5'-di-o-acylated nucleosides for hcv treatment
|
KR20090017498A
(ko)
|
2006-04-04 |
2009-02-18 |
더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 |
Pi3 키나제 길항물질
|
MX2008013119A
(es)
|
2006-04-11 |
2008-10-21 |
Novartis Ag |
Inhibidores de hcv/vih y sus usos.
|
GB0609492D0
(en)
|
2006-05-15 |
2006-06-21 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
GB0612423D0
(en)
|
2006-06-23 |
2006-08-02 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
US7842672B2
(en)
|
2006-07-07 |
2010-11-30 |
Gilead Sciences, Inc. |
Phosphonate inhibitors of HCV
|
US7655419B2
(en)
*
|
2006-08-25 |
2010-02-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for identifying anti-HCV agents
|
EA018935B1
(ru)
|
2006-10-10 |
2013-11-29 |
Медивир Аб |
Нуклеозидный ингибитор для вгс (hcv)
|
CA2666098C
(en)
|
2006-10-10 |
2012-09-25 |
Steven D. Axt |
Preparation of nucleosides ribofuranosyl pyrimidines
|
CA2667266C
(en)
*
|
2006-10-24 |
2015-11-24 |
Merck & Co., Inc. |
Hcv ns3 protease inhibitors
|
EP2079479B1
(en)
*
|
2006-10-24 |
2014-11-26 |
Merck Sharp & Dohme Corp. |
Hcv ns3 protease inhibitors
|
WO2008051477A2
(en)
|
2006-10-24 |
2008-05-02 |
Merck & Co., Inc. |
Hcv ns3 protease inhibitors
|
WO2008057208A2
(en)
*
|
2006-10-27 |
2008-05-15 |
Merck & Co., Inc. |
Hcv ns3 protease inhibitors
|
AU2007318165B2
(en)
|
2006-10-27 |
2011-11-17 |
Msd Italia S.R.L. |
HCV NS3 protease inhibitors
|
KR101165936B1
(ko)
|
2006-11-09 |
2012-07-19 |
에프. 호프만-라 로슈 아게 |
티아졸 및 옥사졸-치환된 아릴아마이드
|
PL2104674T3
(pl)
|
2006-11-15 |
2013-12-31 |
Vertex Pharmaceuticals Canada Incorporated |
Analogi tiofenu do leczenia lub zapobiegania zakażeniom flawiwirusowym
|
GB0623493D0
(en)
|
2006-11-24 |
2007-01-03 |
Univ Cardiff |
Chemical compounds
|
GB0625349D0
(en)
|
2006-12-20 |
2007-01-31 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
CN103224506A
(zh)
*
|
2006-12-20 |
2013-07-31 |
P.安杰莱蒂分子生物学研究所 |
抗病毒的吲哚
|
GB0625345D0
(en)
|
2006-12-20 |
2007-01-31 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
US7951789B2
(en)
|
2006-12-28 |
2011-05-31 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
US8071568B2
(en)
|
2007-01-05 |
2011-12-06 |
Merck Sharp & Dohme Corp. |
Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection
|
TW200838550A
(en)
*
|
2007-02-09 |
2008-10-01 |
Novartis Ag |
Organic compounds
|
NZ579295A
(en)
|
2007-02-27 |
2012-03-30 |
Vertex Pharma |
Inhibitors of serine proteases
|
AU2008219607B2
(en)
|
2007-02-27 |
2013-09-12 |
Vertex Pharmaceuticals Incorporated |
Co-crystals and pharmaceutical compositions comprising the same
|
WO2008106167A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
|
ATE525068T1
(de)
|
2007-02-28 |
2011-10-15 |
Conatus Pharmaceuticals Inc |
Verfahren zur behandlung von chronischer viraler hepatitis c mithilfe von ro 113-0830
|
PT2308514E
(pt)
|
2007-03-23 |
2013-09-06 |
To Bbb Holding B V |
Conjugados para a administração orientada de medicamentos através da barreira hematoencefálica
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
AU2008251555B2
(en)
*
|
2007-05-10 |
2012-08-30 |
Biocryst Pharmaceuticals, Inc. |
Tetrahydrofuro [3 4-D] dioxolane compounds for use in the treatment of viral infections and cancer
|
GB0709791D0
(en)
*
|
2007-05-22 |
2007-06-27 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
WO2009005615A1
(en)
*
|
2007-06-27 |
2009-01-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for identifying agents that inhibit an ns4b-mediated neoplastic cellular phenotype of hcv infected cells
|
CN100532388C
(zh)
*
|
2007-07-16 |
2009-08-26 |
郑州大学 |
2’-氟-4’-取代-核苷类似物、其制备方法及应用
|
WO2009010783A1
(en)
|
2007-07-17 |
2009-01-22 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa |
Macrocyclic indole derivatives for the treatment of hepatitis c infections
|
CA2699891C
(en)
|
2007-07-19 |
2013-10-22 |
Nigel Liverton |
Macrocyclic compounds as antiviral agents
|
ATE530546T1
(de)
|
2007-08-30 |
2011-11-15 |
Vertex Pharma |
Kokristalle und pharmazeutische zusammensetzungen damit
|
GB0718575D0
(en)
|
2007-09-24 |
2007-10-31 |
Angeletti P Ist Richerche Bio |
Nucleoside derivatives as inhibitors of viral polymerases
|
GB2467670B
(en)
|
2007-10-04 |
2012-08-01 |
Intellikine Inc |
Chemical entities and therapeutic uses thereof
|
US20090318380A1
(en)
*
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
US8648085B2
(en)
|
2007-11-30 |
2014-02-11 |
Boehringer Ingelheim International Gmbh |
1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders
|
WO2009077365A1
(en)
|
2007-12-17 |
2009-06-25 |
F. Hoffmann-La Roche Ag |
Novel imidazole-substituted arylamides
|
SI2234976T1
(sl)
|
2007-12-17 |
2013-07-31 |
F. Hoffmann-La Roche Ag |
Novi s pirazolom substituirani arilamidi
|
CA2708228C
(en)
|
2007-12-17 |
2016-06-21 |
F. Hoffmann-La Roche Ag |
Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists
|
EP2225213B1
(en)
|
2007-12-17 |
2015-04-29 |
F. Hoffmann-La Roche AG |
Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists
|
SG10201605472WA
(en)
|
2008-01-04 |
2016-09-29 |
Intellikine Llc |
Certain Chemical Entities, Compositions And Methods
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
US8637542B2
(en)
|
2008-03-14 |
2014-01-28 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
WO2009114874A2
(en)
|
2008-03-14 |
2009-09-17 |
Intellikine, Inc. |
Benzothiazole kinase inhibitors and methods of use
|
US8227431B2
(en)
*
|
2008-03-17 |
2012-07-24 |
Hetero Drugs Limited |
Nucleoside derivatives
|
TW200946541A
(en)
|
2008-03-27 |
2009-11-16 |
Idenix Pharmaceuticals Inc |
Solid forms of an anti-HIV phosphoindole compound
|
UA105362C2
(en)
|
2008-04-02 |
2014-05-12 |
Бьорингер Ингельхайм Интернациональ Гмбх |
1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
|
US8415321B2
(en)
*
|
2008-04-15 |
2013-04-09 |
Raymond F. Schinazi |
Nucleoside derivatives for treatment of Caliciviridae infections, including Norovirus infections
|
KR101681559B1
(ko)
*
|
2008-04-23 |
2016-12-01 |
길리애드 사이언시즈, 인코포레이티드 |
항바이러스 치료를 위한 1'-치환된 카바-뉴클레오사이드 유사체
|
AU2013216595B2
(en)
*
|
2008-04-23 |
2016-07-28 |
Gilead Sciences, Inc. |
1' -substituted carba-nucleoside analogs for antiviral treatment
|
WO2009134624A1
(en)
|
2008-04-28 |
2009-11-05 |
Merck & Co., Inc. |
Hcv ns3 protease inhibitors
|
JP5820722B2
(ja)
|
2008-06-06 |
2015-11-24 |
スシネキス インク |
シクロスポリン類似体及びhcv感染の治療におけるその使用
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
JP2011522552A
(ja)
*
|
2008-06-13 |
2011-08-04 |
リボックス・ゲーエムベーハー |
化学的に修飾されたrnaの酵素的合成のための方法
|
ES2458358T3
(es)
*
|
2008-07-02 |
2014-05-05 |
Idenix Pharmaceuticals, Inc. |
Compuestos y composiciones farmacéuticas para el tratamiento de infecciones víricas
|
EP2313102A2
(en)
|
2008-07-03 |
2011-04-27 |
Biota Scientific Management |
Bycyclic nucleosides and nucleotides as therapeutic agents
|
US20110224223A1
(en)
*
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
WO2010005986A1
(en)
|
2008-07-08 |
2010-01-14 |
Gilead Sciences, Inc. |
Salts of hiv inhibitor compounds
|
KR20110039326A
(ko)
|
2008-07-08 |
2011-04-15 |
인텔리카인, 인크. |
키나제 억제제 및 사용 방법
|
PT2540350E
(pt)
|
2008-07-22 |
2014-08-27 |
Merck Sharp & Dohme |
Combinações de um composto de quinoxalina macrocílico o qual é um inibidor da protease ns3 do hcv com outros agentes do hcv
|
JP5146785B2
(ja)
*
|
2008-07-24 |
2013-02-20 |
国立大学法人九州大学 |
酵素基質修飾ヌクレオシド三リン酸誘導体
|
JP4621926B2
(ja)
*
|
2008-07-24 |
2011-02-02 |
国立大学法人九州大学 |
酵素基質修飾ヌクレオシド三リン酸、核酸プローブ、マルチラベル化核酸プローブ、マルチラベル化核酸プローブの製造方法および標的核酸の検出方法
|
WO2010015637A1
(en)
*
|
2008-08-06 |
2010-02-11 |
Novartis Ag |
New antiviral modified nucleosides
|
EA019204B1
(ru)
|
2008-08-11 |
2014-01-30 |
ГЛАКСОСМИТКЛАЙН ЭлЭлСи |
Производные аденина и их применение в терапии
|
EA201100114A1
(ru)
|
2008-08-11 |
2011-10-31 |
ГЛАКСОСМИТКЛАЙН ЭлЭлСи |
Производные пурина для применения в лечении аллергических, воспалительных и инфекционных заболеваний
|
UA103195C2
(uk)
|
2008-08-11 |
2013-09-25 |
Глаксосмитклайн Ллк |
Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
|
CA2736304A1
(en)
|
2008-09-08 |
2010-03-11 |
Boehringer Ingelheim International Gmbh |
Pyrazolopyrimidines and their use for the treatment of cns disorders
|
EP2346508B1
(en)
|
2008-09-26 |
2016-08-24 |
Intellikine, LLC |
Heterocyclic kinase inhibitors
|
EP3025727A1
(en)
|
2008-10-02 |
2016-06-01 |
The J. David Gladstone Institutes |
Methods of treating liver disease
|
WO2010045542A2
(en)
|
2008-10-16 |
2010-04-22 |
The Regents Of The University Of California |
Fused ring heteroaryl kinase inhibitors
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
JP5645840B2
(ja)
|
2008-12-02 |
2014-12-24 |
株式会社Wave Life Sciences Japan |
リン原子修飾核酸の合成方法
|
AU2009329917B2
(en)
|
2008-12-23 |
2016-03-31 |
Gilead Pharmasset Llc |
Nucleoside analogs
|
KR20110104074A
(ko)
*
|
2008-12-23 |
2011-09-21 |
파마셋 인코포레이티드 |
퓨린 뉴클레오시드의 합성
|
EP2376088B1
(en)
|
2008-12-23 |
2017-02-22 |
Gilead Pharmasset LLC |
6-O-Substituted-2-amino-purine nucleoside phosphoramidates
|
WO2010082050A1
(en)
|
2009-01-16 |
2010-07-22 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Macrocyclic and 7-aminoalkyl-substituted benzoxazocines for treatment of hepatitis c infections
|
GB0900914D0
(en)
|
2009-01-20 |
2009-03-04 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
RU2489153C2
(ru)
*
|
2009-01-21 |
2013-08-10 |
Ф.Хоффманн-Ля Рош Аг |
Фармацевтические композиции, включающие пролекарство ингибитора полимеразы hcv
|
DK2396340T3
(en)
*
|
2009-02-10 |
2014-03-10 |
Gilead Sciences Inc |
Carbanucleosidanaloge to antiviral therapy
|
WO2010093843A2
(en)
|
2009-02-12 |
2010-08-19 |
Vertex Pharmaceuticals Incorporated |
Hcv combination therapies
|
US8193372B2
(en)
|
2009-03-04 |
2012-06-05 |
Idenix Pharmaceuticals, Inc. |
Phosphothiophene and phosphothiazole HCV polymerase inhibitors
|
US8975247B2
(en)
|
2009-03-18 |
2015-03-10 |
The Board Of Trustees Of The Leland Stanford Junion University |
Methods and compositions of treating a flaviviridae family viral infection
|
EA201190178A1
(ru)
*
|
2009-03-20 |
2012-06-29 |
Алиос Биофарма, Инк. |
Замещённые нуклеозидные и нуклеотидные аналоги
|
PT2414363E
(pt)
|
2009-03-31 |
2014-02-26 |
Boehringer Ingelheim Int |
Derivados de 1-heterociclil-1,5-di-hidro-pirazolo[3,4- d]pirimidin-4-ona e sua utilização como moduladores de pde9a
|
US8512690B2
(en)
|
2009-04-10 |
2013-08-20 |
Novartis Ag |
Derivatised proline containing peptide compounds as protease inhibitors
|
US20110182850A1
(en)
|
2009-04-10 |
2011-07-28 |
Trixi Brandl |
Organic compounds and their uses
|
JP5721275B2
(ja)
*
|
2009-04-22 |
2015-05-20 |
インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエス シーアール, ブイ.ブイ.アイ. |
治療的使用のための新規7−デアザプリンヌクレオシド
|
EP2427195B1
(en)
|
2009-05-07 |
2019-05-01 |
Intellikine, LLC |
Heterocyclic compounds and uses thereof
|
JO3027B1
(ar)
*
|
2009-05-14 |
2016-09-05 |
Janssen Products Lp |
نيوكليوسيدات يوراسيل سبيرواوكسيتان
|
WO2010135520A1
(en)
*
|
2009-05-20 |
2010-11-25 |
Chimerix, Inc. |
Compounds, compositions and methods for treating viral infection
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
TWI583692B
(zh)
|
2009-05-20 |
2017-05-21 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
WO2010149578A2
(en)
|
2009-06-22 |
2010-12-29 |
F. Hoffmann-La Roche Ag |
Novel biphenyl and phenyl-pyridine amides
|
CN102438989B
(zh)
|
2009-06-22 |
2015-05-27 |
霍夫曼-拉罗奇有限公司 |
噁唑酮和吡咯烷酮取代的芳基酰胺
|
CA2761921A1
(en)
|
2009-06-22 |
2010-12-29 |
F. Hoffmann-La Roche Ag |
Indole, indazole and benzimidazole arylamides
|
EP2451461A4
(en)
|
2009-07-06 |
2013-05-29 |
Ontorii Inc |
NOVEL NUCLEIC ACID PRODRUGS AND METHOD OF USE THEREOF
|
US8828930B2
(en)
|
2009-07-30 |
2014-09-09 |
Merck Sharp & Dohme Corp. |
Hepatitis C virus NS3 protease inhibitors
|
CA2769652A1
(en)
|
2009-08-05 |
2011-02-10 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
|
TW201118099A
(en)
|
2009-08-12 |
2011-06-01 |
Boehringer Ingelheim Int |
New compounds for the treatment of CNS disorders
|
US8796394B2
(en)
*
|
2009-08-27 |
2014-08-05 |
Northwestern University |
Antifouling hydrogels, coatings, and methods of synthesis and use thereof
|
ES2730805T3
(es)
*
|
2009-09-21 |
2019-11-12 |
Gilead Sciences Inc |
Análogos de carba-nucleósido sustituido por 2'-fluoro para el tratamiento antiviral
|
US7973013B2
(en)
|
2009-09-21 |
2011-07-05 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
US8455451B2
(en)
*
|
2009-09-21 |
2013-06-04 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
WO2011035250A1
(en)
|
2009-09-21 |
2011-03-24 |
Gilead Sciences, Inc. |
Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs
|
WO2011047384A2
(en)
|
2009-10-16 |
2011-04-21 |
The Regents Of The University Of California |
Methods of inhibiting ire1
|
CA2778949C
(en)
|
2009-10-30 |
2018-02-27 |
Janssen Pharmaceutica Nv |
Imidazo[1,2-b]pyridazine derivatives and their use as pde10 inhibitors
|
RU2012122637A
(ru)
|
2009-11-14 |
2013-12-20 |
Ф.Хоффманн-Ля Рош Аг |
Биомаркеры для прогнозирования быстрого ответа на лечение гепатита с
|
AU2010319999B2
(en)
*
|
2009-11-16 |
2014-01-16 |
University Of Georgia Research Foundation, Inc. |
2'-Fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections
|
WO2011063076A1
(en)
|
2009-11-19 |
2011-05-26 |
Itherx Pharmaceuticals, Inc. |
Methods of treating hepatitis c virus with oxoacetamide compounds
|
EP2504329A1
(en)
|
2009-11-25 |
2012-10-03 |
Vertex Pharmaceuticals Incorporated |
5-alkynyl-thiophene-2-carboxylic acid derivatives and their use for the treatment or prevention of flavivirus infections
|
SG181104A1
(en)
|
2009-12-02 |
2012-07-30 |
Hoffmann La Roche |
Biomarkers for predicting sustained response to hcv treatment
|
MX2012006877A
(es)
|
2009-12-18 |
2012-08-31 |
Idenix Pharmaceuticals Inc |
Inhibidores de virus de hepatitis c de arileno o heteroarileno 5, 5 - fusionado.
|
MX2012007420A
(es)
|
2009-12-24 |
2012-07-23 |
Vertex Pharma |
Analogos para el tratamiento o prevencion de infecciones de flavivirus.
|
JP5704481B2
(ja)
*
|
2010-01-22 |
2015-04-22 |
国立大学法人九州大学 |
核酸検出用キット
|
MX337050B
(es)
*
|
2010-01-28 |
2016-02-10 |
Riboscience Llc |
Compuestos 4'-azido-nucleósidos como anti-vhc.
|
JP2013518124A
(ja)
|
2010-01-29 |
2013-05-20 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
C型肝炎ウイルス感染の処置のための治療法
|
WO2011098452A1
(en)
|
2010-02-10 |
2011-08-18 |
Glaxosmithkline Llc |
6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
|
EP2534148A1
(en)
|
2010-02-10 |
2012-12-19 |
GlaxoSmithKline LLC |
Purine derivatives and their pharmaceutical uses
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
EP2550268A1
(en)
|
2010-03-24 |
2013-01-30 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
JP2013522377A
(ja)
|
2010-03-24 |
2013-06-13 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
フラビウイルス感染を処置または予防するためのアナログ
|
EP2550262A1
(en)
|
2010-03-24 |
2013-01-30 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
MX2012010918A
(es)
|
2010-03-24 |
2013-01-18 |
Vertex Pharma |
Analogos para el tratamiento o prevencion de infecciones por flavivirus.
|
US8563530B2
(en)
|
2010-03-31 |
2013-10-22 |
Gilead Pharmassel LLC |
Purine nucleoside phosphoramidate
|
WO2011123672A1
(en)
|
2010-03-31 |
2011-10-06 |
Pharmasset, Inc. |
Purine nucleoside phosphoramidate
|
HUE034239T2
(en)
|
2010-03-31 |
2018-02-28 |
Gilead Pharmasset Llc |
Method for Crystallization of (S) -isopropyl 2 - (((S) (perfluorophenoxy) (phenoxy) phosphoryl) amino) propanoate \ t
|
US8680071B2
(en)
|
2010-04-01 |
2014-03-25 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
WO2011146882A1
(en)
|
2010-05-21 |
2011-11-24 |
Intellikine, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
TW201201815A
(en)
|
2010-05-28 |
2012-01-16 |
Gilead Sciences Inc |
1'-substituted-carba-nucleoside prodrugs for antiviral treatment
|
WO2011156545A1
(en)
|
2010-06-09 |
2011-12-15 |
Vertex Pharmaceuticals Incorporated |
Viral dynamic model for hcv combination therapy
|
WO2011159826A2
(en)
|
2010-06-15 |
2011-12-22 |
Vertex Pharmaceuticals Incorporated |
Hcv ns5b protease mutants
|
WO2012006070A1
(en)
|
2010-06-28 |
2012-01-12 |
Vertex Pharmaceuticals Incorporated |
Compounds and methods for the treatment or prevention of flavivirus infections
|
JP2013531011A
(ja)
|
2010-06-28 |
2013-08-01 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
フラビウイルス感染の処置または予防のための化合物および方法
|
MX2012014918A
(es)
|
2010-06-28 |
2013-04-08 |
Vertex Pharma |
Compuestos y metodos para tratamiento o prevencion de infecciones por flavivirus.
|
EP2593105A1
(en)
|
2010-07-14 |
2013-05-22 |
Vertex Pharmaceuticals Incorporated |
Palatable pharmaceutical composition comprising vx-950
|
EP2596004B1
(en)
|
2010-07-19 |
2014-09-10 |
Gilead Sciences, Inc. |
Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
|
MX2013000744A
(es)
|
2010-07-22 |
2013-03-07 |
Gilead Sciences Inc |
Metodos y compuestos para tratar infecciones virales por paramyxoviridae.
|
UA110347C2
(uk)
|
2010-08-12 |
2015-12-25 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
ПОХІДНІ 6-ЦИКЛОАЛКІЛ-1,5-ДИГІДРОПІРАЗОЛО[3,4-d]ПІРИМІДИН-4-ОНУ І ЇХ ЗАСТОСУВАННЯ ЯК ІНГІБІТОРІВ PDE9A
|
MX2013001869A
(es)
|
2010-08-17 |
2013-06-28 |
Vertex Pharma |
Compuestos y metodos para el tratamiento o prevencion de infecciones virales por flaviviridae.
|
JP2013538230A
(ja)
*
|
2010-09-20 |
2013-10-10 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス治療用の2’−フルオロ置換カルバヌクレオシド類似体
|
CA2812962C
(en)
|
2010-09-22 |
2020-03-31 |
Alios Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
CN103209987B
(zh)
|
2010-09-22 |
2017-06-06 |
艾丽奥斯生物制药有限公司 |
取代的核苷酸类似物
|
EP2620428B1
(en)
|
2010-09-24 |
2019-05-22 |
Wave Life Sciences Ltd. |
Asymmetric auxiliary group
|
AU2011311880B2
(en)
|
2010-10-08 |
2014-07-24 |
Novartis Ag |
Vitamin E formulations of sulfamide NS3 inhibitors
|
CN103298474B
(zh)
|
2010-11-10 |
2016-06-29 |
无限药品股份有限公司 |
杂环化合物及其用途
|
TW201242974A
(en)
|
2010-11-30 |
2012-11-01 |
Gilead Pharmasset Llc |
Compounds
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
AU2011349278C1
(en)
|
2010-12-22 |
2017-01-19 |
Alios Biopharma, Inc. |
Cyclic nucleotide analogs
|
AR084824A1
(es)
|
2011-01-10 |
2013-06-26 |
Intellikine Inc |
Procesos para preparar isoquinolinonas y formas solidas de isoquinolinonas
|
US9353100B2
(en)
|
2011-02-10 |
2016-05-31 |
Idenix Pharmaceuticals Llc |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
|
WO2012109646A1
(en)
|
2011-02-11 |
2012-08-16 |
Vertex Pharmaceuticals Incorporated |
Treatment of hcv in hiv infection patients
|
US20130040971A1
(en)
|
2011-02-14 |
2013-02-14 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders
|
US8809345B2
(en)
|
2011-02-15 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
|
CN103491962B
(zh)
|
2011-02-23 |
2016-10-12 |
因特利凯有限责任公司 |
激酶抑制剂的组合及其用途
|
JP2014514295A
(ja)
|
2011-03-31 |
2014-06-19 |
アイディニックス ファーマシューティカルズ インコーポレイテッド |
ウイルス感染の治療のための化合物および薬学的組成物
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
WO2012142085A1
(en)
|
2011-04-13 |
2012-10-18 |
Merck Sharp & Dohme Corp. |
2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
US9150603B2
(en)
|
2011-04-13 |
2015-10-06 |
Merck Sharp & Dohme Corp. |
2′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases
|
AU2012242517B2
(en)
|
2011-04-13 |
2016-12-15 |
Gilead Sciences, Inc. |
1'-substituted pyrimidine N-nucleoside analogs for antiviral treatment
|
WO2012142075A1
(en)
|
2011-04-13 |
2012-10-18 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
JP6115962B2
(ja)
|
2011-06-27 |
2017-04-19 |
ヤンセン ファーマシューティカ エヌ.ベー. |
1−アリール−4−メチル−[1,2,4]トリアゾロ[4,3−a]キノキサリン誘導体
|
US9416154B2
(en)
|
2011-07-13 |
2016-08-16 |
Merck Sharp & Dohme Corp. |
5′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
EP2731433A4
(en)
|
2011-07-13 |
2014-12-31 |
Merck Sharp & Dohme |
5'-SUBSTITUTED NUCLEOSIDE ANALOGUES AND METHODS OF USE FOR THE TREATMENT OF VIRAL DISEASES
|
US8969363B2
(en)
|
2011-07-19 |
2015-03-03 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
CA2842190A1
(en)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
US9605019B2
(en)
|
2011-07-19 |
2017-03-28 |
Wave Life Sciences Ltd. |
Methods for the synthesis of functionalized nucleic acids
|
AR087345A1
(es)
|
2011-07-26 |
2014-03-19 |
Vertex Pharma |
Metodos para la preparacion de compuestos de tiofeno
|
WO2013016499A1
(en)
|
2011-07-26 |
2013-01-31 |
Vertex Pharmaceuticals Incorporated |
Methods for preparation of thiophene compounds
|
RU2014111823A
(ru)
|
2011-08-29 |
2015-10-10 |
Инфинити Фармасьютикалз, Инк. |
Гетероциклические соединения и их применения
|
LT2750768T
(lt)
|
2011-08-30 |
2019-02-11 |
Astex Pharmaceuticals, Inc. |
Decitabino darinio kompozicijos
|
US9988680B2
(en)
|
2011-09-01 |
2018-06-05 |
Case Western Reserve University |
Non-natural nucleosides as theranostic agents
|
CA2846496C
(en)
|
2011-09-02 |
2020-07-14 |
The Regents Of The University Of California |
Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
|
JP2014526474A
(ja)
|
2011-09-12 |
2014-10-06 |
アイディニックス ファーマシューティカルズ インコーポレイテッド |
ウイルス感染の治療のための化合物および薬学的組成物
|
EP2755983B1
(en)
|
2011-09-12 |
2017-03-15 |
Idenix Pharmaceuticals LLC. |
Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
|
SG11201400664WA
(en)
|
2011-09-16 |
2014-04-28 |
Gilead Pharmassett Llc |
Methods for treating hcv
|
WO2013056046A1
(en)
|
2011-10-14 |
2013-04-18 |
Idenix Pharmaceuticals, Inc. |
Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
|
US8492386B2
(en)
|
2011-10-21 |
2013-07-23 |
Abbvie Inc. |
Methods for treating HCV
|
DE202012013117U1
(de)
|
2011-10-21 |
2015-01-16 |
Abbvie Inc. |
Kombinationsbehandlung (z.B. mit ABT-072 oder ABT-333 von DAAs zur Verwendung in der Behandlung von HCV)
|
US8466159B2
(en)
|
2011-10-21 |
2013-06-18 |
Abbvie Inc. |
Methods for treating HCV
|
DE112012003510T5
(de)
|
2011-10-21 |
2015-03-19 |
Abbvie Inc. |
Verfahren zur Behandlung von HCV umfassend mindestens zwei direkt wirkende antivirale Wirkstoffe, Ribavirin aber nicht Interferon
|
EP2776438A4
(en)
*
|
2011-11-10 |
2015-04-29 |
Inhibitex Inc |
SUBSTITUTED PURIN NUCLEOSIDES, PHOSPHORAMIDATE AND PHOSPHORDIAMIDATE DERIVATIVES FOR THE TREATMENT OF VIRUS INFECTIONS
|
EP2780026B1
(en)
|
2011-11-15 |
2019-10-23 |
Merck Sharp & Dohme Corp. |
Hcv ns3 protease inhibitors
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
EP3750544A3
(en)
|
2011-11-30 |
2021-03-24 |
Emory University |
Jak inhibitors for use in the prevention or treatment of viral infection
|
WO2013084165A1
(en)
*
|
2011-12-05 |
2013-06-13 |
Medivir Ab |
Hcv polymerase inhibitors
|
US9364484B2
(en)
|
2011-12-06 |
2016-06-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for treating viral diseases
|
CN107459544B
(zh)
|
2011-12-22 |
2021-03-16 |
詹森生物制药有限公司 |
取代的核苷、核苷酸及其类似物
|
AU2013235220C1
(en)
|
2011-12-22 |
2019-03-28 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
EP2794630A4
(en)
|
2011-12-22 |
2015-04-01 |
Alios Biopharma Inc |
SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE
|
WO2013106344A1
(en)
|
2012-01-12 |
2013-07-18 |
Ligand Pharmaceuticals, Inc. |
2 '-c-methyl nucleosides containing a cyclic phosphate diester of 1, 3-propanediol (2-oxo-[1, 3, 2]-dioxaphosphorinane) at position 5'
|
WO2013116339A1
(en)
|
2012-01-31 |
2013-08-08 |
Vertex Pharmaceuticals Incorporated |
High potency formulations of vx-950
|
US20130217644A1
(en)
|
2012-02-13 |
2013-08-22 |
Idenix Pharmaceuticals, Inc. |
Pharmaceutical Compositions of 2'-C-Methyl-Guanosine, 5'-[2[(3-Hydroxy-2,2-Dimethyl-1-Oxopropyl)Thio]Ethyl N-(Phenylmethyl)Phosphoramidate]
|
AU2013221571A1
(en)
|
2012-02-14 |
2014-08-28 |
University Of Georgia Research Foundation, Inc. |
Spiro [2.4] heptanes for treatment of Flaviviridae infections
|
SI2834258T1
(sl)
*
|
2012-03-13 |
2017-04-26 |
Gilead Sciences, Inc. |
2'-substituirani karba-nukleozidni analogi za protivirusno zdravljenje
|
CN104321333A
(zh)
|
2012-03-21 |
2015-01-28 |
沃泰克斯药物股份有限公司 |
硫代氨基磷酸酯核苷酸前药的固体形式
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
USRE48171E1
(en)
|
2012-03-21 |
2020-08-25 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
NZ630805A
(en)
|
2012-03-22 |
2016-01-29 |
Alios Biopharma Inc |
Pharmaceutical combinations comprising a thionucleotide analog
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US9296778B2
(en)
|
2012-05-22 |
2016-03-29 |
Idenix Pharmaceuticals, Inc. |
3′,5′-cyclic phosphate prodrugs for HCV infection
|
US9109001B2
(en)
|
2012-05-22 |
2015-08-18 |
Idenix Pharmaceuticals, Inc. |
3′,5′-cyclic phosphoramidate prodrugs for HCV infection
|
EP2852603B1
(en)
|
2012-05-22 |
2021-05-12 |
Idenix Pharmaceuticals LLC |
D-amino acid compounds for liver disease
|
UY34824A
(es)
|
2012-05-25 |
2013-11-29 |
Janssen R & D Ireland |
Nucleósidos de espirooxetano de uracilo
|
US9206412B2
(en)
*
|
2012-05-31 |
2015-12-08 |
Colorado State University Research Foundation |
Thioxothiazolidine inhibitors
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
WO2014001314A1
(en)
|
2012-06-26 |
2014-01-03 |
Janssen Pharmaceutica Nv |
Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders
|
ES2607184T3
(es)
|
2012-07-09 |
2017-03-29 |
Janssen Pharmaceutica, N.V. |
Inhibidores de la enzima fosfodiesterasa 10
|
BR112015000784A8
(pt)
|
2012-07-13 |
2018-04-03 |
Wave Life Sciences Japan |
Grupo auxiliar assimétrico
|
PL2872147T3
(pl)
|
2012-07-13 |
2023-09-25 |
Wave Life Sciences Ltd. |
Sposób wytwarzania chiralnych oligonukleotydów
|
RU2677639C2
(ru)
|
2012-07-13 |
2019-01-18 |
Шин Ниппон Биомедикал Лэбораториз, Лтд. |
Хиральный адъювант нуклеиновой кислоты
|
WO2014033617A1
(en)
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
2'-ethynyl nucleoside derivatives for treatment of viral infections
|
KR20150061651A
(ko)
|
2012-09-26 |
2015-06-04 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
Ire1의 조절
|
EP2900682A1
(en)
|
2012-09-27 |
2015-08-05 |
IDENIX Pharmaceuticals, Inc. |
Esters and malonates of sate prodrugs
|
SG11201502750UA
(en)
|
2012-10-08 |
2015-06-29 |
Idenix Pharmaceuticals Inc |
2'-chloro nucleoside analogs for hcv infection
|
US9457039B2
(en)
|
2012-10-17 |
2016-10-04 |
Merck Sharp & Dohme Corp. |
2′-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
US9242988B2
(en)
|
2012-10-17 |
2016-01-26 |
Merck Sharp & Dohme Corp. |
2′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
AR092959A1
(es)
|
2012-10-17 |
2015-05-06 |
Merck Sharp & Dohme |
Derivados de nucleosidos 2-metil sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales
|
US20140112886A1
(en)
|
2012-10-19 |
2014-04-24 |
Idenix Pharmaceuticals, Inc. |
Dinucleotide compounds for hcv infection
|
WO2014066239A1
(en)
|
2012-10-22 |
2014-05-01 |
Idenix Pharmaceuticals, Inc. |
2',4'-bridged nucleosides for hcv infection
|
US20140140951A1
(en)
|
2012-11-14 |
2014-05-22 |
Idenix Pharmaceuticals, Inc. |
D-Alanine Ester of Rp-Nucleoside Analog
|
WO2014078436A1
(en)
|
2012-11-14 |
2014-05-22 |
Idenix Pharmaceuticals, Inc. |
D-alanine ester of sp-nucleoside analog
|
WO2014078463A1
(en)
|
2012-11-19 |
2014-05-22 |
Merck Sharp & Dohme Corp. |
2 -alkynyl substituted nucleoside derivatives for treating viral diseases
|
WO2014099941A1
(en)
|
2012-12-19 |
2014-06-26 |
Idenix Pharmaceuticals, Inc. |
4'-fluoro nucleosides for the treatment of hcv
|
SG11201504554UA
(en)
*
|
2012-12-21 |
2015-07-30 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
CA2894541A1
(en)
|
2012-12-21 |
2014-06-26 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
PT2950786T
(pt)
|
2013-01-31 |
2020-03-03 |
Gilead Pharmasset Llc |
Formulação de combinação de dois compostos antivirais
|
WO2014121417A1
(en)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
|
WO2014121416A1
(en)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
|
WO2014121418A1
(en)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
|
US9821173B2
(en)
*
|
2013-02-08 |
2017-11-21 |
Case Western Reserve University |
Anti-cancer agents and methods of use
|
US20150065439A1
(en)
|
2013-02-28 |
2015-03-05 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
WO2014137926A1
(en)
|
2013-03-04 |
2014-09-12 |
Idenix Pharmaceuticals, Inc. |
3'-deoxy nucleosides for the treatment of hcv
|
WO2014137930A1
(en)
|
2013-03-04 |
2014-09-12 |
Idenix Pharmaceuticals, Inc. |
Thiophosphate nucleosides for the treatment of hcv
|
US20140271547A1
(en)
|
2013-03-13 |
2014-09-18 |
Idenix Pharmaceuticals, Inc. |
Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
RU2534613C2
(ru)
|
2013-03-22 |
2014-11-27 |
Александр Васильевич Иващенко |
Алкил 2-{ [(2r,3s,5r)-5-(4-амино-2-оксо-2н-пиримидин-1-ил)- -гидрокси-тетрагидро-фуран-2-илметокси]-фенокси-фосфориламино} -пропионаты, нуклеозидные ингибиторы рнк-полимеразы hcv ns5b, способы их получения и применения
|
US9187515B2
(en)
|
2013-04-01 |
2015-11-17 |
Idenix Pharmaceuticals Llc |
2′,4′-fluoro nucleosides for the treatment of HCV
|
BR112015025716A2
(pt)
|
2013-04-12 |
2017-07-18 |
Achillion Pharmaceuticals Inc |
pró-fármacos de nucleosídeo submetidos a deutério úteis para o tratamento de hcv
|
WO2014197578A1
(en)
|
2013-06-05 |
2014-12-11 |
Idenix Pharmaceuticals, Inc. |
1',4'-thio nucleosides for the treatment of hcv
|
US9422322B2
(en)
|
2013-06-26 |
2016-08-23 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
US9815864B2
(en)
|
2013-06-26 |
2017-11-14 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
EP3027636B1
(en)
|
2013-08-01 |
2022-01-05 |
Idenix Pharmaceuticals LLC |
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
|
PT3038601T
(pt)
|
2013-08-27 |
2020-06-30 |
Gilead Pharmasset Llc |
Formulação combinada de dois compostos antivirais
|
WO2015042447A1
(en)
|
2013-09-20 |
2015-03-26 |
Isis Pharmaceuticals, Inc. |
Targeted therapeutic nucleosides and their use
|
EP3046924A1
(en)
|
2013-09-20 |
2016-07-27 |
IDENIX Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
MY175778A
(en)
|
2013-10-04 |
2020-07-08 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and uses thereof
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
CA2927010C
(en)
|
2013-10-11 |
2022-06-07 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2015061683A1
(en)
|
2013-10-25 |
2015-04-30 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate and d-alanine thiophosphoramidate pronucleotides of nucleoside compounds useful for the treatment of hcv
|
WO2015066370A1
(en)
|
2013-11-01 |
2015-05-07 |
Idenix Pharmaceuticals, Inc. |
D-alanine phosphoramidate pronucleotides of 2'-methyl 2'-fluoro guanosine nucleoside compounds for the treatment of hcv
|
CZ305466B6
(cs)
*
|
2013-11-04 |
2015-10-14 |
Ústav organické chemie a biochemie Akademie věd České republiky, v. v. i. |
Substituované 7-deazapurinové ribonukleosidy pro terapeutické použití
|
EP3074399A1
(en)
|
2013-11-27 |
2016-10-05 |
Idenix Pharmaceuticals LLC |
2'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infection
|
US10683321B2
(en)
|
2013-12-18 |
2020-06-16 |
Idenix Pharmaceuticals Llc |
4′-or nucleosides for the treatment of HCV
|
US10144933B2
(en)
|
2014-01-15 |
2018-12-04 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
|
WO2015108046A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
|
EP3095459A4
(en)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having antitumor effect and antitumor agent
|
CN113278617A
(zh)
|
2014-01-16 |
2021-08-20 |
波涛生命科学有限公司 |
手性设计
|
US10449210B2
(en)
|
2014-02-13 |
2019-10-22 |
Ligand Pharmaceuticals Inc. |
Prodrug compounds and their uses
|
WO2015124591A1
(en)
|
2014-02-20 |
2015-08-27 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Pyrrolo[3,2] pyrimidine derivatives as inducers of human interferon
|
WO2015134560A1
(en)
|
2014-03-05 |
2015-09-11 |
Idenix Pharmaceuticals, Inc. |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
WO2015134561A1
(en)
|
2014-03-05 |
2015-09-11 |
Idenix Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising a 5,5-fused heteroarylene flaviviridae inhibitor and their use for treating or preventing flaviviridae infection
|
SG11201607705XA
(en)
|
2014-03-19 |
2016-10-28 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
|
EP3131914B1
(en)
*
|
2014-04-16 |
2023-05-10 |
Idenix Pharmaceuticals LLC |
3'-substituted methyl or alkynyl nucleosides for the treatment of hcv
|
WO2015160975A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
WO2015191303A2
(en)
*
|
2014-06-10 |
2015-12-17 |
Agilent Technologies, Inc. |
Protecting groups for "z nucleotide" and methods thereof
|
AU2015280248B2
(en)
|
2014-06-24 |
2021-04-08 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
MX2016017381A
(es)
|
2014-06-24 |
2017-08-14 |
Alios Biopharma Inc |
Nucleosidos sustituidos, nucleotidos y analogos de los mismos.
|
JP2017520545A
(ja)
|
2014-07-02 |
2017-07-27 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
プロドラッグ化合物およびそれらの使用
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
TWI740546B
(zh)
|
2014-10-29 |
2021-09-21 |
美商基利科學股份有限公司 |
製備核糖苷的方法
|
BR112017009648A2
(pt)
|
2014-11-13 |
2017-12-19 |
Glaxosmithkline Biologicals Sa |
composto, métodos para tratamento de doenças alérgicas ou outras condições inflamatórias ou prevenção de doença, de rinite alérgica ou asma, composição, e, uso de um composto.
|
MA41213A
(fr)
|
2014-12-19 |
2017-10-24 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
MA41441A
(fr)
|
2014-12-19 |
2017-12-12 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
CA2978085C
(en)
|
2015-03-06 |
2023-01-17 |
Atea Pharmaceuticals, Inc. |
.beta.-d-2'-deoxy-2'-.alpha.-fluoro-2'-.beta.-c-substituted-2-modified-n6-substituted purine nucleotides for hcv treatment
|
ES2933032T3
(es)
|
2015-06-03 |
2023-01-31 |
Teva Pharmaceuticals Int Gmbh |
Procesos mejorados para la preparación de sofosbuvir e intermedios del mismo
|
JP6768722B2
(ja)
|
2015-07-02 |
2020-10-14 |
大塚製薬株式会社 |
凍結乾燥医薬組成物
|
AU2016301188A1
(en)
|
2015-08-06 |
2018-02-15 |
Chimerix, Inc. |
Pyrrolopyrimidine nucleosides and analogs thereof useful as antiviral agents
|
UA123701C2
(uk)
|
2015-08-13 |
2021-05-19 |
Мерк Шарп І Доум Корп. |
Циклічні динуклеотидні сполуки як агоністи sting
|
CA2997170A1
(en)
|
2015-09-02 |
2017-03-09 |
Abbvie Inc. |
Anti-viral tetrahydrofurane derivatives
|
JP6980649B2
(ja)
|
2015-09-14 |
2021-12-15 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
イソキノリノン誘導体の固体形態、それを製造する方法、それを含む組成物、及びそれを使用する方法
|
US10251904B2
(en)
|
2015-09-16 |
2019-04-09 |
Gilead Sciences, Inc. |
Methods for treating arenaviridae and coronaviridae virus infections
|
CN108289931B
(zh)
*
|
2015-09-23 |
2022-10-11 |
默沙东公司 |
4’-取代的核苷逆转录酶抑制剂及其制备
|
EP3366691A1
(en)
|
2015-12-03 |
2018-08-29 |
GlaxoSmithKline Intellectual Property Development Limited |
Cyclic purine dinucleotides as modulators of sting
|
TWI740910B
(zh)
|
2016-03-09 |
2021-10-01 |
美商艾洛斯生物製藥公司 |
非環抗病毒劑
|
US10759806B2
(en)
|
2016-03-17 |
2020-09-01 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
|
FI3433257T3
(fi)
|
2016-03-24 |
2024-01-08 |
Novartis Ag |
Alkynyylinukleosidianalogeja ihmisen rinoviruksen estäjinä
|
AU2017247806B2
(en)
|
2016-04-07 |
2019-11-14 |
Glaxosmithkline Intellectual Property Development Limited |
Heterocyclic amides useful as protein modulators
|
CA3019630A1
(en)
|
2016-04-07 |
2017-10-12 |
Glaxosmithkline Intellectual Property Development Limited |
Heterocyclic amides useful as protein modulators
|
CN109689063A
(zh)
|
2016-04-28 |
2019-04-26 |
埃默里大学 |
含有炔烃的核苷酸和核苷治疗组合物及其相关用途
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
EP3474856B1
(en)
|
2016-06-24 |
2022-09-14 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
US10202412B2
(en)
|
2016-07-08 |
2019-02-12 |
Atea Pharmaceuticals, Inc. |
β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections
|
WO2018013937A1
(en)
|
2016-07-14 |
2018-01-18 |
Atea Pharmaceuticals, Inc. |
Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection
|
US20190169221A1
(en)
*
|
2016-08-12 |
2019-06-06 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2018048937A1
(en)
|
2016-09-07 |
2018-03-15 |
Atea Pharmaceuticals, Inc. |
2'-substituted-n6-substituted purine nucleotides for rna virus treatment
|
WO2018089306A1
(en)
*
|
2016-11-10 |
2018-05-17 |
Oyagen, Inc. |
Methods of treating and inhibiting ebola virus infection
|
AU2017368050A1
(en)
|
2016-11-29 |
2019-06-20 |
Puretech Lyt, Inc. |
Exosomes for delivery of therapeutic agents
|
WO2018110643A1
(ja)
*
|
2016-12-14 |
2018-06-21 |
ヤマサ醤油株式会社 |
抗ウイルス活性を示すヌクレオシド誘導体
|
CN110248951B
(zh)
|
2017-02-01 |
2022-10-28 |
阿堤亚制药公司 |
用于治疗丙型肝炎病毒的核苷酸半硫酸盐
|
KR102318320B1
(ko)
|
2017-03-14 |
2021-10-27 |
길리애드 사이언시즈, 인코포레이티드 |
고양이 코로나바이러스 감염의 치료 방법
|
EP4219513A1
(en)
|
2017-05-01 |
2023-08-02 |
Gilead Sciences, Inc. |
Crystalline form of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
|
CA3077489A1
(en)
|
2017-07-11 |
2019-01-17 |
Gilead Sciences, Inc. |
Compositions comprising an rna polymerase inhibitor and cyclodextrin for treating viral infections
|
WO2019027920A1
(en)
|
2017-08-01 |
2019-02-07 |
Gilead Sciences, Inc. |
CRYSTALLINE FORMS OF ETHYL ((S) - (((((2R, 5R) -5- (6-AMINO-9H-PURIN-9-YL) -4-FLUORO-2,5-DIHYDROFURAN-2-YL) OXY ) METHYL) (PHENOXY) PHOSPHORYL) -L-ALANINATE (GS-9131) FOR THE TREATMENT OF VIRAL INFECTIONS
|
CA3071755A1
(en)
|
2017-08-03 |
2019-02-07 |
Otsuka Pharmaceutical Co., Ltd. |
Drug compound and purification methods thereof
|
WO2019053696A1
(en)
|
2017-09-18 |
2019-03-21 |
Alios Biopharma, Inc. |
SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
|
WO2019060692A1
(en)
|
2017-09-21 |
2019-03-28 |
Chimerix, Inc. |
MORPHIC FORMS OF 4-AMINO-7- (3,4-DIHYDROXY-5- (HYDROXYMETHYL) -ETRAHYDROFURAN-2-YL) -2-METHYL-7H-PYRROLO [2,3-D] PYRIMIDINE-5-CARBOXAMIDE AND THEIR USES
|
JP7291130B2
(ja)
|
2017-10-05 |
2023-06-14 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド |
インターフェロン遺伝子の刺激物質(sting)の調節物質
|
EP3692033A1
(en)
|
2017-10-05 |
2020-08-12 |
GlaxoSmithKline Intellectual Property Development Limited |
Modulators of stimulator of interferon genes (sting) useful in treating hiv
|
JP7417529B2
(ja)
|
2018-03-07 |
2024-01-18 |
サノフイ |
ヌクレオチド前駆体、ヌクレオチド類似体およびこれを含むオリゴマー化合物
|
WO2019200005A1
(en)
|
2018-04-10 |
2019-10-17 |
Atea Pharmaceuticals, Inc. |
Treatment of hcv infected patients with cirrhosis
|
CN112384228A
(zh)
|
2018-04-12 |
2021-02-19 |
莫迪斯治疗公司 |
用于治疗由失衡的核苷酸池引起的疾病的脱氧核苷的前药
|
GB201807924D0
(en)
|
2018-05-16 |
2018-06-27 |
Ctxt Pty Ltd |
Compounds
|
CA3122410A1
(en)
|
2018-12-12 |
2020-06-18 |
Janssen Biopharma, Inc. |
Cyclopentyl nucleoside analogs as anti-virals
|
CN113939504A
(zh)
|
2018-12-12 |
2022-01-14 |
詹森生物制药有限公司 |
作为抗病毒药的环丁基核苷类似物
|
JP2022533194A
(ja)
|
2019-05-16 |
2022-07-21 |
スティングセラ インコーポレイテッド |
ベンゾ[b][1,8]ナフチリジン酢酸誘導体および使用方法
|
EP3969438A1
(en)
|
2019-05-16 |
2022-03-23 |
Stingthera, Inc. |
Oxoacridinyl acetic acid derivatives and methods of use
|
GB201910304D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
GB201910305D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
CN114728999A
(zh)
|
2019-09-05 |
2022-07-08 |
赛诺菲 |
含有核苷酸类似物的寡核苷酸
|
TWI789695B
(zh)
|
2020-01-27 |
2023-01-11 |
美商基利科學股份有限公司 |
治療sars cov-2感染之方法
|
WO2021158248A1
(en)
|
2020-02-04 |
2021-08-12 |
Oyagen, Inc. |
Method for treating coronavirus infections
|
US10874687B1
(en)
|
2020-02-27 |
2020-12-29 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against COVID-19
|
CN115298181A
(zh)
|
2020-03-12 |
2022-11-04 |
吉利德科学公司 |
制备1’-氰基核苷的方法
|
WO2021207049A1
(en)
|
2020-04-06 |
2021-10-14 |
Gilead Sciences, Inc. |
Inhalation formulations of 1'-cyano substituted carbanucleoside analogs
|
KR20230018473A
(ko)
|
2020-05-29 |
2023-02-07 |
길리애드 사이언시즈, 인코포레이티드 |
렘데시비르 치료 방법
|
IL299202A
(en)
|
2020-06-24 |
2023-02-01 |
Gilead Sciences Inc |
1'-cyano nucleoside analogs and uses thereof
|
EP4204421A2
(en)
|
2020-08-27 |
2023-07-05 |
Gilead Sciences, Inc. |
Compounds and methods for treatment of viral infections
|
JP2023546199A
(ja)
|
2020-10-20 |
2023-11-01 |
サノフイ |
アシアロ糖タンパク質受容体のための新規リガンド
|
CN112979735B
(zh)
*
|
2021-04-25 |
2021-09-17 |
南京颐媛生物医学研究院有限公司 |
抗肝炎病毒的化合物及其制备方法和应用
|
CN113278041B
(zh)
*
|
2021-07-16 |
2021-10-19 |
南京颐媛生物医学研究院有限公司 |
一种核苷磷酸酯及其合成方法与抗肝炎病毒的制药应用
|
TW202400185A
(zh)
|
2022-03-02 |
2024-01-01 |
美商基利科學股份有限公司 |
用於治療病毒感染的化合物及方法
|
CN115651047B
(zh)
*
|
2022-11-14 |
2023-03-17 |
天津奥瑞芙生物医药有限公司 |
2’-o-甲基核苷的制备方法
|